Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 3 | 0 | 0 | 3 |
Chain A, MTA/SAH nucleosidase | 0 | 1 | 0 | 1 |
Chain A, Ribosome-inactivating protein alpha-trichosanthin | 0 | 0 | 1 | 1 |
Chain A, Ricin A chain | 0 | 0 | 1 | 1 |
Chain A, Ribosome-inactivating protein 3 | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
RAR-related orphan receptor gamma | 7 | 0 | 0 | 7 |
TDP1 protein | 7 | 0 | 0 | 7 |
AR protein | 10 | 0 | 0 | 10 |
nuclear receptor subfamily 1, group I, member 3 | 9 | 0 | 0 | 9 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 6 | 0 | 0 | 6 |
glucocorticoid receptor [Homo sapiens] | 8 | 0 | 0 | 8 |
estrogen-related nuclear receptor alpha | 8 | 0 | 0 | 8 |
pregnane X nuclear receptor | 10 | 0 | 0 | 10 |
estrogen nuclear receptor alpha | 12 | 0 | 0 | 12 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 8 | 0 | 0 | 8 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 3 | 0 | 0 | 3 |
heat shock protein beta-1 | 3 | 0 | 0 | 3 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
snurportin-1 | 1 | 0 | 0 | 1 |
tumor susceptibility gene 101 protein | 1 | 0 | 0 | 1 |
GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 8 | 0 | 0 | 8 |
Voltage-dependent calcium channel gamma-2 subunit | 3 | 0 | 0 | 3 |
Bile salt export pump | 0 | 15 | 0 | 15 |
Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
Heat shock protein HSP 90-beta | 0 | 1 | 0 | 1 |
Glutamate receptor 2 | 3 | 0 | 0 | 3 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
TAR DNA-binding protein 43 | 4 | 0 | 0 | 4 |
Protein mono-ADP-ribosyltransferase PARP15 | 0 | 1 | 0 | 1 |
Leucine-rich repeat serine/threonine-protein kinase 2 | 0 | 2 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 4 | 0 | 0 | 4 |
Ataxin-2 | 4 | 0 | 0 | 4 |
thioredoxin reductase | 5 | 0 | 0 | 5 |
ATAD5 protein, partial | 1 | 0 | 0 | 1 |
Microtubule-associated protein tau | 2 | 0 | 0 | 2 |
arylsulfatase A | 4 | 0 | 0 | 4 |
euchromatic histone-lysine N-methyltransferase 2 | 11 | 0 | 0 | 11 |
Bloom syndrome protein isoform 1 | 4 | 0 | 0 | 4 |
D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
NPYLR7B | 0 | 0 | 1 | 1 |
Amine oxidase [flavin-containing] A | 0 | 0 | 1 | 1 |
Small conductance calcium-activated potassium channel protein 3 | 0 | 1 | 1 | 2 |
Chain A, 2-oxoglutarate Oxygenase | 1 | 0 | 0 | 1 |
GLI family zinc finger 3 | 6 | 0 | 0 | 6 |
retinoid X nuclear receptor alpha | 4 | 0 | 0 | 4 |
cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
DNA polymerase beta | 2 | 0 | 0 | 2 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 1 | 0 | 5 | 0 | 5 |
ATP-binding cassette sub-family C member 3 | 0 | 9 | 0 | 9 |
Multidrug resistance-associated protein 4 | 0 | 9 | 0 | 9 |
5-hydroxytryptamine receptor 4 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M2 | 0 | 4 | 1 | 8 |
Muscarinic acetylcholine receptor M4 | 0 | 3 | 1 | 6 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M5 | 0 | 3 | 1 | 6 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 1 | 6 |
Muscarinic acetylcholine receptor M1 | 0 | 3 | 1 | 7 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 4 | 1 | 7 |
Alpha-1D adrenergic receptor | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 2C | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 2 | 0 | 0 | 3 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 1 | 1 | 3 |
Canalicular multispecific organic anion transporter 1 | 0 | 9 | 0 | 9 |
Potassium channel subfamily K member 3 | 0 | 2 | 0 | 2 |
Potassium channel subfamily K member 3 | 0 | 2 | 0 | 2 |
Potassium channel subfamily K member 2 | 0 | 0 | 2 | 2 |
Potassium channel subfamily K member 9 | 0 | 2 | 0 | 2 |
Chain A, Glycogen Phosphorylase | 0 | 1 | 0 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Chitinase | 0 | 1 | 0 | 1 |
phosphopantetheinyl transferase | 2 | 0 | 0 | 2 |
GLS protein | 5 | 0 | 0 | 5 |
retinoic acid nuclear receptor alpha variant 1 | 9 | 0 | 0 | 9 |
farnesoid X nuclear receptor | 5 | 0 | 0 | 5 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 3 | 0 | 0 | 3 |
atrial natriuretic peptide receptor 1 precursor | 2 | 0 | 0 | 2 |
chromobox protein homolog 1 | 4 | 0 | 0 | 4 |
thyroid hormone receptor beta isoform a | 3 | 0 | 0 | 3 |
thyroid hormone receptor beta isoform 2 | 5 | 0 | 0 | 5 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 7 | 0 | 0 | 7 |
nuclear receptor ROR-gamma isoform 1 | 3 | 0 | 0 | 3 |
geminin | 9 | 0 | 0 | 9 |
DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
muscarinic acetylcholine receptor M1 | 6 | 0 | 0 | 6 |
lethal factor (plasmid) | 1 | 0 | 0 | 1 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Cholinesterase | 0 | 4 | 0 | 4 |
Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Adenosine receptor A3 | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 2 | 0 | 2 |
Acetylcholinesterase | 0 | 4 | 0 | 4 |
Adenosine receptor A1 | 0 | 2 | 0 | 3 |
Amine oxidase [flavin-containing] B | 0 | 3 | 0 | 3 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Adenosine receptor A3 | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 2 | 1 | 4 |
Adenosine receptor A2b | 0 | 1 | 0 | 2 |
Adenosine receptor A2b | 0 | 2 | 0 | 3 |
Adenosine receptor A1 | 0 | 1 | 1 | 4 |
Adenosine receptor A2a | 0 | 2 | 0 | 4 |
Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
DNA-dependent protein kinase catalytic subunit | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Adenylate cyclase type 1 | 0 | 1 | 1 | 3 |
Chitotriosidase-1 | 0 | 1 | 0 | 1 |
Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase ATR | 0 | 1 | 0 | 1 |
Adenosine receptor A2b | 0 | 1 | 0 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 2 | 3 |
Endochitinase B1 | 0 | 1 | 0 | 1 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
Guanine deaminase | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 1 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 2 | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit pi | 2 | 7 | 1 | 10 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 3 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 3 | 0 | 5 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 3 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 3 | 0 | 5 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 5 | 2 | 7 |
Gamma-aminobutyric acid receptor subunit beta-1 | 2 | 7 | 1 | 10 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 4 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit delta | 2 | 7 | 1 | 10 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 5 | 2 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 2 | 7 | 1 | 10 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 2 | 7 | 1 | 10 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 2 | 7 | 1 | 10 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 3 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 3 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 2 | 7 | 1 | 10 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 2 | 7 | 1 | 10 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 2 | 7 | 1 | 10 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 5 | 2 | 7 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 2 | 7 | 1 | 10 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 2 | 7 | 1 | 10 |
Translocator protein | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 1 | 0 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 4 | 2 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 4 | 2 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 4 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 4 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 4 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 2 | 7 | 1 | 10 |
Gamma-aminobutyric acid receptor subunit beta-3 | 2 | 7 | 1 | 10 |
Gamma-aminobutyric acid receptor subunit beta-2 | 2 | 7 | 1 | 10 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 4 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 4 | 0 | 4 |
GABA theta subunit | 2 | 7 | 1 | 10 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit epsilon | 2 | 7 | 1 | 10 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 4 | 0 | 4 |
glp-1 receptor, partial | 1 | 0 | 0 | 1 |
pregnane X receptor | 2 | 0 | 0 | 2 |
estrogen receptor 2 (ER beta) | 2 | 0 | 0 | 2 |
progesterone receptor | 3 | 0 | 0 | 3 |
G | 5 | 0 | 0 | 5 |
peroxisome proliferator-activated receptor delta | 2 | 0 | 0 | 2 |
peroxisome proliferator activated receptor gamma | 3 | 0 | 0 | 3 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 3 | 0 | 0 | 3 |
aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
nuclear receptor subfamily 0 group B member 1 | 0 | 1 | 0 | 1 |
steroidogenic factor 1 | 0 | 1 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 | 5 | 0 | 0 | 5 |
relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
relaxin receptor 2 isoform 1 | 1 | 0 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
Rap guanine nucleotide exchange factor 3 | 2 | 0 | 0 | 2 |
Interferon beta | 5 | 0 | 0 | 5 |
HLA class I histocompatibility antigen, B alpha chain | 5 | 0 | 0 | 5 |
Cellular tumor antigen p53 | 6 | 0 | 0 | 6 |
ATP-dependent translocase ABCB1 | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 0 | 1 | 1 |
Adenylate cyclase type 2 | 0 | 0 | 1 | 1 |
Adenylate cyclase type 8 | 0 | 0 | 1 | 1 |
Inositol hexakisphosphate kinase 1 | 5 | 0 | 0 | 5 |
Relaxin receptor 1 | 0 | 0 | 1 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
cytochrome P450 2C9, partial | 5 | 0 | 0 | 5 |
thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
cytochrome P450 2C9 precursor | 2 | 0 | 0 | 2 |
cytochrome P450 3A4 isoform 1 | 2 | 0 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-1B adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-1A adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-2C adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1D adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
Cytochrome P450 2D6 | 0 | 2 | 0 | 3 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
Luciferase | 2 | 0 | 0 | 2 |
potassium voltage-gated channel subfamily H member 2 isoform d | 2 | 0 | 0 | 2 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
D(4) dopamine receptor | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 4 | 1 | 6 |
Delta-type opioid receptor | 0 | 5 | 1 | 6 |
Mu-type opioid receptor | 0 | 7 | 2 | 9 |
Kappa-type opioid receptor | 0 | 4 | 1 | 5 |
Histamine H1 receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 5 | 5 | 13 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 5 | 3 | 11 |
Kappa-type opioid receptor | 0 | 5 | 0 | 6 |
Kappa-type opioid receptor | 0 | 5 | 1 | 10 |
Mu-type opioid receptor | 0 | 3 | 1 | 5 |
Mu-type opioid receptor | 0 | 4 | 1 | 6 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 3 | 0 | 3 |
Sigma non-opioid intracellular receptor 1 | 0 | 6 | 0 | 6 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
endonuclease IV | 2 | 0 | 0 | 2 |
aldehyde dehydrogenase 1 family, member A1 | 2 | 0 | 0 | 2 |
regulator of G-protein signaling 4 | 4 | 0 | 0 | 4 |
EWS/FLI fusion protein | 2 | 0 | 0 | 2 |
flap endonuclease 1 | 2 | 0 | 0 | 2 |
survival motor neuron protein isoform d | 1 | 0 | 0 | 1 |
muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
Bile salt export pump | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
Chain A, Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 4 | 1 | 5 |
Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 4 | 1 | 5 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 4 | 1 | 5 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 4 | 1 | 5 |
Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 4 | 1 | 5 |
Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 4 | 1 | 5 |
Serine racemase | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 4 | 1 | 5 |
Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
cytochrome P450 2D6 | 5 | 0 | 0 | 5 |
vitamin D3 receptor isoform VDRA | 2 | 0 | 0 | 2 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 2 | 0 | 3 |
Cholinesterase | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 2 | 0 | 3 |
UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
Fumarate hydratase | 1 | 0 | 0 | 1 |
polyprotein | 1 | 0 | 0 | 1 |
kappa-type opioid receptor isoform 1 | 0 | 1 | 0 | 1 |
Spike glycoprotein | 3 | 0 | 0 | 3 |
Beta-galactosidase | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3E | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
Histidine decarboxylase | 0 | 0 | 1 | 1 |
Kappa-type opioid receptor | 0 | 2 | 1 | 3 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3D | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3C | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 2 |
Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid | 0 | 1 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
Chain A, Ferritin light chain | 3 | 0 | 0 | 3 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
USP1 protein, partial | 2 | 0 | 0 | 2 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
activating transcription factor 6 | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
Histone H2A.x | 2 | 0 | 0 | 2 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 3 | 0 | 3 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent betaine transporter | 0 | 2 | 0 | 2 |
Fatty-acid amide hydrolase 1 | 0 | 2 | 0 | 2 |
Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 1 | 0 | 0 | 1 |
SMAD family member 2 | 1 | 0 | 0 | 1 |
SMAD family member 3 | 1 | 0 | 0 | 1 |
Smad3 | 1 | 0 | 0 | 1 |
PINK1 | 1 | 0 | 0 | 1 |
Parkin | 1 | 0 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
photoreceptor-specific nuclear receptor | 0 | 1 | 0 | 1 |
IDH1 | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
plasminogen precursor | 1 | 0 | 0 | 1 |
urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 1 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 2 | 0 | 2 |
Insulin receptor | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B1 | 0 | 1 | 0 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 1 | 0 | 0 | 1 |
Cocaine esterase | 0 | 1 | 0 | 1 |
Histone deacetylase 3 | 0 | 2 | 0 | 2 |
Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
Tissue factor | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Liver carboxylesterase 1 | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 1 | 0 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Histone deacetylase 4 | 0 | 2 | 0 | 2 |
Histone deacetylase 1 | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B7 | 0 | 1 | 0 | 1 |
Histone deacetylase 7 | 0 | 2 | 0 | 2 |
Histone deacetylase 2 | 0 | 2 | 0 | 2 |
Polyamine deacetylase HDAC10 | 0 | 2 | 0 | 2 |
Histone deacetylase 11 | 0 | 2 | 0 | 2 |
Histone deacetylase 8 | 0 | 2 | 0 | 2 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
Histone deacetylase 6 | 0 | 2 | 0 | 2 |
Histone deacetylase 9 | 0 | 2 | 0 | 2 |
Histone deacetylase 5 | 0 | 2 | 0 | 2 |
acetylcholinesterase | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |